companydata.dkcompanydata.dk

Signum Life Science ApS: Financial statements 2019

CVR: 36559241

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 10,457,442 and a net result of DKK 3,795,326 compared with DKK 4,067,570 the year before. That is a decrease of 13.1% compared with the year before. Equity in the 2019 report amounted to DKK 129,178,418. The solvency ratio was 81.2%. The company had 28 employees in the financial year.

Gross Profit
DKK 10,457,442
Profit/Loss
DKK 3,795,326
Equity
DKK 129,178,418
Total Assets
DKK 159,181,165
Employees
28

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-10.5M3.8M129.2M28
2018-12M4.1M127.5M21
2017-12.5M5.5M125.8M-
2016-11.4M4.8M122.5M16
2015-9.2M2.6M119.5M16

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Thomas Bo Bjørn Klee joins the board of Signum Life Science ApSNov 1, 2019

As of November 1, 2019, Thomas Bo Bjørn Klee has joined the board of directors of Signum Life Science ApS.

Lars Møller joins the board of Signum Life Science ApSNov 1, 2019

As of November 1, 2019, Lars Møller has joined the board of directors of Signum Life Science ApS.

Mads Veggerby Lausten leaves the board of Signum Life Science ApSNov 1, 2019

As of November 1, 2019, Mads Veggerby Lausten has left the board of directors of Signum Life Science ApS.

Lars Møller leaves the board of Signum Life Science ApSOct 31, 2019

As of October 31, 2019, Lars Møller has left the board of directors of Signum Life Science ApS.

Mads Veggerby Lausten joins the board of Signum Life Science ApSJun 21, 2019

As of June 21, 2019, Mads Veggerby Lausten has joined the board of directors of Signum Life Science ApS.

Andreas Daugaard Jørgensen joins the board of Signum Life Science ApSJun 21, 2019

As of June 21, 2019, Andreas Daugaard Jørgensen has joined the board of directors of Signum Life Science ApS.

Christoffer Dahl leaves the board of Signum Life Science ApSJun 21, 2019

As of June 21, 2019, Christoffer Dahl has left the board of directors of Signum Life Science ApS.

Mads Veggerby Lausten leaves the board of Signum Life Science ApSJun 20, 2019

As of June 20, 2019, Mads Veggerby Lausten has left the board of directors of Signum Life Science ApS.

Signum Life Science ApS: The 2018 annual report is outMay 8, 2019

Signum Life Science ApS has published its annual report for 2018. Gross profit came to DKK 12,039,531, and the net result was DKK 4,067,570.

Lars Møller joins the board of Signum Life Science ApSApr 3, 2019

As of April 3, 2019, Lars Møller has joined the board of directors of Signum Life Science ApS.

About Signum Life Science ApS

Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.

Source: annual report 2025, Danish Business Authority